Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) were down 55.7% during mid-day trading on Monday . The company traded as low as $2.70 and last traded at $3.00. Approximately 3,378 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 9,053 shares. The stock had previously closed at $6.77.
Peak Pharmaceuticals Stock Performance
The firm’s 50 day moving average price is $3.60 and its 200 day moving average price is $2.30.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
See Also
- Five stocks we like better than Peak Pharmaceuticals
- Find and Profitably Trade Stocks at 52-Week Lows
- Can TikTok Stock Picks Really Make You Rich?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- The “Quality” Rotation: Back to Basics Investing
- Top Biotech Stocks: Exploring Innovation Opportunities
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
